Drug intelligence / Profile preview

Raksha Biovac

Development stage
Unknown
Lead developer
Indian Immunologicals
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Raksha Biovac is a veterinary combination vaccine developed by Indian Immunologicals Limited (IIL) for the simultaneous immunization of cattle and buffaloes against Foot-and-Mouth Disease (FMD) and Hemorrhagic Septicemia (HS). The vaccine is formulated as an oil-adjuvanted emulsion containing inactivated antigens of Foot-and-Mouth Disease Virus (FMDV) serotypes O, A, and Asia 1, along with inactivated *Pasteurella multocida*. It is designed to stimulate a protective humoral immune response against both viral and bacterial pathogens, thereby reducing the need for separate vaccinations and improving compliance in mass vaccination programs. The vaccine has been extensively utilized in India's national livestock health initiatives, including the Foot-and-Mouth Disease Control Programme (FMD-CP) and the Livestock Health Disease Control Program.

Brand names
Raksha Biovac
Other names
FMD + HS combined vaccineFoot-and-mouth disease plus Hemorrhagic Septicemia combined vaccineFMD-HS vaccine
02

Targets

Foot-and-mouth disease virus structural proteinsP. multocida (Pasteurella multocida)

Beyond the preview

Go deeper on Raksha Biovac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raksha Biovac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call